NRF2 Activation Confers Resistance to eIF4A Inhibitors in Cancer Therapy

অনুযায়ী Sanghvi, Viraj R., Mohan, Prathibha, Singh, Kamini, Cao, Linlin, Berishaj, Marjan, Wolfe, Andrew L., Schatz, Jonathan H., Lailler, Nathalie, de Stanchina, Elisa, Viale, Agnes, Wendel, Hans-Guido
প্রকাশিত Cancers (Basel) (2021)

c-MYC regulates mRNA translation efficiency and start-site selection in lymphoma

অনুযায়ী Singh, Kamini, Lin, Jianan, Zhong, Yi, Burčul, Antonija, Mohan, Prathibha, Jiang, Man, Sun, Liping, Yong-Gonzalez, Vladimir, Viale, Agnes, Cross, Justin R., Hendrickson, Ronald C., Rätsch, Gunnar, Ouyang, Zhengqing, Wendel, Hans-Guido
প্রকাশিত J Exp Med (2019)

Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia

অনুযায়ী Sanghvi, Viraj R., Mavrakis, Konstantinos J., Van der Meulen, Joni, Boice, Michael, Wolfe, Andrew L., Carty, Mark, Mohan, Prathibha, Rondou, Pieter, Socci, Nicholas D., Benoit, Yves, Taghon, Tom, Van Vlierberghe, Pieter, Leslie, Christina S., Speleman, Frank, Wendel, Hans-Guido
প্রকাশিত Sci Signal (2014)

The oncogenic action of NRF2 depends on de-glycation by Fructosamine-3-kinase

অনুযায়ী Sanghvi, Viraj R., Leibold, Josef, Mina, Marco, Mohan, Prathibha, Berishaj, Marjan, Li, Zhuoning, Miele, Matthew M., Lailler, Nathalie, Zhao, Chunying, de Stanchina, Elisa, Viale, Agnes, Akkari, Leila, Lowe, Scott W., Ciriello, Giovanni, Hendrickson, Ronald C., Wendel, Hans-Guido
প্রকাশিত Cell (2019)

Targeting eIF4A Dependent Translation of KRAS Signaling Molecules

অনুযায়ী Singh, Kamini, Lin, Jianan, Lecomte, Nicolas, Mohan, Prathibha, Gokce, Askan, Sanghvi, Viraj R., Jiang, Man, Grbovic-Huezo, Olivera, Burčul, Antonija, Stark, Stefan G., Romesser, Paul B., Chang, Qing, Melchor, Jerry P., Beyer, Rachel K., Duggan, Mark, Fukase, Yoshiyuki, Yang, Guangli, Ouerfelli, Ouathek, Viale, Agnes, de Stanchina, Elisa, Stamford, Andrew W., Meinke, Peter T., Rätsch, Gunnar, Leach, Steven D., Ouyang, Zhengqing, Wendel, Hans-Guido
প্রকাশিত Cancer Res (2021)

The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing

অনুযায়ী Parsa, Sara, Ortega-Molina, Ana, Ying, Hsia-Yuan, Jiang, Man, Teater, Matt, Wang, Jiahui, Zhao, Chunying, Reznik, Ed, Pasion, Joyce P., Kuo, David, Mohan, Prathibha, Wang, Shenqiu, Camarillo, Jeannie M., Thomas, Paul M., Jain, Neeraj, Garcia-Bermudez, Javier, Cho, Byoung-kyu, Tam, Wayne, Kelleher, Neil L., Socci, Nicholas, Dogan, Ahmet, De Stanchina, Elisa, Ciriello, Giovanni, Green, Michael R., Li, Sheng, Birsoy, Kivanc, Melnick, Ari M., Wendel, Hans-Guido
প্রকাশিত Nat Cancer (2020)